Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.810 +0.020 (+1.12%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	352,970
Open	1.790
Bid (Size)	1.750 (800)
Ask (Size)	1.780 (300)
Prev. Close	1.790
Today's Range	1.760 - 1.820
52wk Range	1.300 - 2.979
Shares Outstanding	210,356,896
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INO CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

February 25, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

February 25, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Performance

YTD	+7.1%	+7.1%
1 Month	+18.3%	+18.3%
3 Month	-12.1%	-12.1%
6 Month	-23.6%	-23.6%
1 Year	-6.7%	-6.7%

More News

INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

February 24, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

February 24, 2026

From Pomerantz LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

February 24, 2026

From Schall Law

Via GlobeNewswire

Is Inovio Pharmaceuticals Stock Going to $0? ↗

February 23, 2026

Via The Motley Fool

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

February 20, 2026

From Schall Law

Via GlobeNewswire

Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

February 20, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Deadline Approaching: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

February 19, 2026

From Law Offices of Howard G. Smith

Via Business Wire

INO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

February 19, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Law Offices of Frank R. Cruz Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action

February 18, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders to Inquire About Securities Fraud Class Action

February 17, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

February 17, 2026

From Pomerantz LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

February 17, 2026

From Schall Law

Via GlobeNewswire

INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

February 14, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

February 13, 2026

From Schall Law

Via GlobeNewswire

INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action

February 13, 2026

From Robbins LLP

Via GlobeNewswire

Law Offices of Howard G. Smith Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action

February 13, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

February 12, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

February 12, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

February 12, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – INO

February 12, 2026

From DJS Law Group

Via Business Wire

INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

February 11, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

February 11, 2026

From The Schall Law Firm

Via Business Wire

Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights

February 09, 2026

From Rosen Law Firm

Via Business Wire

Frequently Asked Questions

Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?

Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market

What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?

The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.810

When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 02/27/26 04:00 PM ET

What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 380.75M

How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?

Inovio Pharmaceuticals, Inc. - Common Stock has 381M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.